Low-level Laser Therapy in Patients With Chronic Fibromyalgia
TerminatedNot applicableNCT02948634
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to examine the use of low level therapeutic laser (LLLT) for its effects on pain, fatigue, and physical function in individuals with fibromyalgia.
Study details
- Official title
- A Prospective, Randomized, Double-blind, Sham-controlled Study of the Low-level Phoenix Thera-lase 42 Watt Laser in Patients With Chronic Fibromyalgia
- Conditions
- Interventions
- Device: Sham Phoenix Laser Treatment
- Device: Active Phoenix Laser Treatment
- Sponsor
- University of Texas Southwestern Medical Center
- Start date
- 2016-10
- Primary completion
- 2019-06
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. 18-80 years old 2. Pre-existing medical conditions are under stable control 3. Diagnosis of fibromyalgia by Widespread Pain Index and Symptom Severity Score 4. Able to wear laser protective eyewear during the treatment session 5. Ability to speak English and complete testing Exclusion Criteria: 1. Presence of another pain syndrome that has anatomical overlapping with fibromyalgia pain 2. Unstable psychiatric disorders or cognitive dysfunction or serious memory impairment 3. Previous treatment with low level laser therapy 4. Contraindication to receiving laser treatments 5. Current use of photosensitive medication (has been instructed to minimize sun exposure) 6. Active metastasis 7. Active infection 8. Impaired sensation
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02948634